FDA
approval
· 2025-03-07
FDA Approved: GLATOPA — Supplemental Application (Sandoz Inc)
Summary
FDA approves GLATOPA (glatiramer acetate) under a supplemental application by Sandoz, providing a generic option for multiple sclerosis. The product is a generi…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for GLATOPA (GLATIRAMER ACETATE)